In yesterday’s Wall Street session, Amicus Therapeutics Inc (NASDAQ:FOLD) shares traded at $10.98, down -2.31% from the previous session.
FOLD stock price is now -1.42% away from the 50-day moving average and -1.25% away from the 200-day moving average. The market capitalization of the company currently stands at $3.26B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $18, Jefferies recently initiated with Buy rating for Amicus Therapeutics Inc (NASDAQ: FOLD). On May 30, 2024, Wells Fargo recently initiated its ‘Overweight’ rating on the stock quoting a target price of $18, while ‘Guggenheim’ rates the stock as ‘Buy’
In other news, Campbell Bradley L, President and CEO sold 7,901 shares of the company’s stock on Nov 06 ’24. The stock was sold for $98,800 at an average price of $12.50. Upon completion of the transaction, the President and CEO now directly owns 886,654 shares in the company, valued at $9.74 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 06 ’24, Director BRADLEY CAMPBELL bought 7,901 shares of the business’s stock. A total of $92,758 was incurred on buying the stock at an average price of $11.74. A total of 2.55% of the company’s stock is owned by insiders.
During the past 12 months, Amicus Therapeutics Inc has had a low of $9.02 and a high of $14.57. As of last week, the company has a debt-to-equity ratio of 2.49, a current ratio of 3.15, and a quick ratio of 2.42. The fifty day moving average price for FOLD is $11.1422 and a two-hundred day moving average price translates $11.12685 for the stock.
The latest earnings results from Amicus Therapeutics Inc (NASDAQ: FOLD) was released for 2024-06-30. The net profit margin was -21.21% and return on equity was -67.09% for FOLD. The company reported revenue of $141.52 million for the quarter, compared to $103.5 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 36.73 percent.
